Profil
David A. Snyder formerly worked at Teva Pharmaceutical Industries Ltd., as Principal, Gensia Pharmaceuticals, Inc., as Principal, Gamida Cell Ltd., as VP-Clinical Development & Regulatory Affairs, Proneuron Biotechnologies, Inc., as Vice President-Clinical Development, Collgard Biopharmaceuticals Ltd., as Vice President-Drug Development, and Vascular Biogenics Ltd., as Vice President-Clinical Development.
Dr. Snyder received his doctorate degree from The Hebrew University of Jerusalem.
Anciens postes connus de David A. Snyder
| Sociétés | Poste | Fin |
|---|---|---|
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
| NOTABLE LABS, LTD. | Corporate Officer/Principal | - |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Gensia Pharmaceuticals, Inc.
Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for cardiovascular diseases | Corporate Officer/Principal | - |
Collgard Biopharmaceuticals Ltd.
Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures tissue therapeutics | Corporate Officer/Principal | - |
Formation de David A. Snyder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Gensia Pharmaceuticals, Inc.
Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for cardiovascular diseases | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nervous disorders | Health Technology |
Collgard Biopharmaceuticals Ltd.
Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures tissue therapeutics | Health Technology |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
















